JZJanis Ya-Xian Zhan

Janis Ya-Xian Zhan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Janis Ya-Xian Zhan has a total of 99 co-authors. Here are the top co-authors by number of shared publications:

  • Zi-Ren Su

    School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, PR China

    4 shared publications
  • Qing-Yuan Zhong

    School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China

    3 shared publications
  • Xie Zhang

    School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China

    3 shared publications
  • Bao-Qin Lin

    School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, No. 223 Waihuan Road, Guangzhou 510006, PR China

    2 shared publications
  • Bing Lin

    School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, No. 223 Waihuan Road, Guangzhou 510006, PR China

    2 shared publications
  • Jie Yuan

    Mathematical Engineering Academy of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China

    2 shared publications

Latest Publications

  • Tuihong formula attenuates DNCB-induced atopic dermatitis in mice via suppression of MAPK/NF-κB signaling and epidermal barrier restoration

    by Yingqi Huang, Weijun Lin, Xiaoyan Chen, Fuyuan Lin, Jiajie Li, Yaosheng Liu, Yumei Liu, Guangpu Luo, Xianhua Du, Lixin Duan, et al.

  • Open Access

    Prevention of supercritical carbon dioxide fluid extract from Chrysanthemum indicum Linnén on cutaneous squamous cell carcinomas progression following UV irradiation in mice

    by Qi-Hong Luo, Hong-Juan Chen, Qing-Yuan Zhong, Hao-En He, Ying-Qi Huang, You-Chen Liu, Bin Lan, Yao-Qi Wen, Si-Liang Deng, Xian-Hua Du, et al.

    Chrysanthemum indicum Linnén (C. indicum), a medicinal and food herb with various bioactive components, may be of beneficial use in cosmetics and the treatment of skin‑related diseases. However, to date, few studies have been reported on its potential preventive and therapeutic effects on skin cancer. Therefore, the present study aimed to investigate the effect and potential mechanism of action of supercritical carbon dioxide extract from C. indicum (CISCFE) on UV‑induced skin cancer in a mouse model. Kunming mice were allocated randomly to five treatment groups: Sham, model, low concentration CISCFE, high concentration CISCFE and positive control nicotinamide groups. The dorsal skin of mice was irradiated with UV light for 31 weeks. Histopathological changes, ELISA assays, immunohistochemical analysis and western blotting were performed to investigate the potential therapeutic effects of CISCFE. The results showed that CISCFE alleviated skin oxidative and inflammatory damage in a UV‑induced mouse model of skin cancer. Moreover, CISCFE suppressed abnormal activation of proto‑oncogene c‑Myc and the overexpression of Ki‑67 and VEGF, and increased expression of the anti‑oncogene PTEN, thereby reducing abnormal proliferation of the epidermis and blood vessels. Additionally, CISCFE increased the protein expression levels of NAD‑dependent protein deacetylase sirtuin‑1 (SIRT1), Kelch‑like ECH associated protein 1 (Keap1) and inhibited the expression of nuclear factor 2 erythroid 2‑related factor 2 (Nrf2), phosphorylated (p)‑p62 (Ser 349), p‑p65 and acetyl‑p65 proteins in a UV‑induced skin cancer mouse model. In summary, CISCFE exhibited potent anti‑skin cancer activity, which may be attributed its potential effects on the p62/Keap1‑Nrf2 and SIRT1/NF‑κB pathways.


  • Open Access

    Protective effects of andrographolide sodium bisulfate on UV-induced skin carcinogenesis in mice model

    by Qing-Yuan Zhong, Qi-Hong Luo, Bing Lin, Bao-Qin Lin, Zi-Ren Su, Janis Ya-Xian Zhan


  • Open Access

    Protective Effects of Oxyberberine in 5-Fluorouracil-Induced Intestinal Mucositis in the Mice Model

    by Ronglei Huang, Gaoxiang Ai, Linjiang Zhong, Liting Mai, Jian-Nan Chen, Yuhong Liu, Yucui Li, Xiaoqi Huang, Ziren Su, Janis Ya-Xian Zhan

    Berberine (BBR), a major active constituent of Rhizoma coptidis, was reported to exert beneficial effects on intestinal mucositis (IM) induced by 5-fluorouracil (5-FU). However, the bioavailability of BBR is extremely low, and its metabolites were perceived to contribute to its prominent pharmacological activities. Oxyberberine (OBB) is a gut metabolite of BBR, which has been reported to have a superior anti-inflammatory effect in experimental colitis. However, its anti-inflammatory effects against 5-FU-induced IM mice have not yet been investigated. Hence, the purpose of this study was to reveal the protective effects of OBB on IM induced by 5-FU and investigate its potential underlying mechanism. The IM mice model was induced by receiving 5-FU (60mg/kg, i.p.) for five days. Meanwhile, BBR (50mg/kg) and OBB (12.5, 25, and 50mg/kg) were given prior to 30min intraperitoneal injection of 5-FU for seven days. Results indicated that OBB ameliorated body weight loss, anorexia, diarrhea, and histopathological damage in 5-FU-induced IM mice. After OBB administration, the amounts of MDA, SOD, and GSH altered by IM were remarkably restored. OBB was also observed to dramatically decrease the levels of TNF-α, IL-8, IL-6, COX-2, and iNOS and promote the release of IL-10. Besides, OBB distinctly upregulated the mRNA expressions of PCNA, ZO-1, occludin, and mucin-1, which could improve intestinal homeostasis in IM mice. OBB also blocked the activation of the upstream TLR4/MyD88 signaling pathway, and then it inhibited the phosphorylation of the NF-κB and MAPK pathways. Importantly, compared with BBR, OBB displayed a superior therapeutic effect to BBR in alleviating 5-FU-induced IM mice. These results indicated that OBB has considerable potential to become a novel candidate drug against IM.


  • Open Access

    Binding Interaction of Betulinic Acid to α-Glucosidase and Its Alleviation on Postprandial Hyperglycemia

    by Shaodan Chen, Bing Lin, Jiangyong Gu, Tianqiao Yong, Xiong Gao, Yizhen Xie, Chun Xiao, Janis Yaxian Zhan, Qingping Wu

    Inhibiting the intestinal α-glucosidase can effectively control postprandial hyperglycemia for type 2 diabetes mellitus (T2DM) treatment. In the present study, we reported the binding interaction of betulinic acid (BA), a pentacyclic triterpene widely distributed in nature, on α-glucosidase and its alleviation on postprandial hyperglycemia. BA was verified to exhibit a strong inhibitory effect against α-glucosidase with an IC50 value of 16.83 ± 1.16 μM. More importantly, it showed a synergistically inhibitory effect with acarbose. The underlying inhibitory mechanism was investigated by kinetics analysis, surface plasmon resonance (SPR) detection, molecular docking, molecular dynamics (MD) simulation and binding free energy calculation. BA showed a non-competitive inhibition on α-glucosidase. SPR revealed that it had a strong and fast affinity to α-glucosidase with an equilibrium dissociation constant (KD) value of 5.529 × 10−5 M and a slow dissociation. Molecular docking and MD simulation revealed that BA bound to the active site of α-glucosidase mainly due to the van der Waals force and hydrogen bond, and then changed the micro-environment and secondary structure of α-glucosidase. Free energy decomposition indicated amino acid residues such as PHE155, PHE175, HIE277, PHE298, GLU302, TRY311 and ASP347 of α-glucosidase at the binding pocket had strong interactions with BA, while LYS153, ARG210, ARG310, ARG354 and ARG437 showed a negative contribution to binding affinity between BA and α-glucosidase. Significantly, oral administration of BA alleviated the postprandial blood glucose fluctuations in mice. This work may provide new insights into the utilization of BA as a functional food and natural medicine for the control of postprandial hyperglycemia.


  • Gender differences in UV-induced skin inflammation, skin carcinogenesis and systemic damage

    by Qing-Yuan Zhong, Bing Lin, Yin-Ting Chen, Yin-Ping Huang, Wei-Peng Feng, Ying Wu, Gui-Hong Long, Yun-Nan Zou, Yu Liu, Bao-Qin Lin, et al.


  • Open Access

    Andrographolide sodium bisulfate attenuates UV‑induced photo‑damage by activating the keap1/Nrf2 pathway and downregulating the NF‑κB pathway in HaCaT keratinocytes

    by Mei‑Ling Wang, Qing‑Yuan Zhong, Bao‑Qin Lin, Yu‑Hong Liu, Yan‑Feng Huang, Yang Chen, Jie Yuan, Zi‑Ren Su, Janis Ya‑Xian Zhan

    Oxidative and inflammatory damage has been suggested to play important roles in the pathogenesis of skin photoaging. Andrographolide sodium bisulfate (ASB) is a soluble derivative of andrographolide and has known antioxidant and anti‑inflammatory properties. In the present study, cellular experiments were designed to investigate the molecular mechanisms underlying the effect of ASB in relieving ultraviolet (UV)‑induced photo‑damage. Following ASB pretreatment and UV irradiation, the apoptosis and necrosis of HaCaT cells were investigated by Hoechst 33342/propidium iodide staining. Reactive oxygen species (ROS) production was investigated using a DCFH‑DA fluorescence probe. Furthermore, the protein expression levels of p65, NF‑κB inhibitor‑α, nuclear factor E2‑related factor 2 (Nrf2) and kelch‑like ECH‑associated protein 1 (keap1) were measured via western blotting and immunofluorescence analyses. Furthermore, NF‑κB‑mediated cytokines were assessed by ELISA, and Nrf2‑mediated genes were detected by reverse transcription‑quantitative PCR. Pretreatment with ASB markedly increased cell viability, decreased cell apoptosis and decreased UV‑induced excess ROS levels. In addition, ASB activated the production of Nrf2 and increased the mRNA expression levels of glutamate‑cysteine ligase catalytic subunit and NAD(P)H quinone oxidoreductase 1, while ASB downregulated the protein expression of p65 and decreased the production of interleukin (IL)‑1β, IL‑6 and tumor necrosis factor‑α. These results suggested that ASB attenuates UV‑induced photo‑damage by activating the keap1/Nrf2 pathway and downregulating the NF‑κB pathway in HaCaT keratinocytes.


  • Open Access

    Different effects of (+)-borneol and (−)-borneol on the pharmacokinetics of osthole in rats following oral administration

    by Dan-Dan Luo, Xiao-Ying Chen, Zhen-Biao Zhang, Chao-Yue Sun, Yi-Feng Zheng, Yu-Hong Liu, Xiu-Fen Wang, Qi Wang, Janis Ya-Xian Zhan, Zi-Ren Su

    Osthole is the primary active component of a number of herbal plants such as the Cnidium monnieri fruit. In traditional Chinese herb medicine, osthole is commonly used in combination with borneol to obtain improved pharmacological effects. The aim of the present study was to investigate the effect of borneol enantiomers on the pharmacokinetics of osthole. An appropriate high‑performance liquid chromatography (HPLC) method was applied to determine the concentrations of osthole in plasma. Following oral administration of osthole alone or combined with borneol in rats, blood samples were collected and analyzed by HPLC. The results demonstrated that there were statistically significant differences in the pharmacokinetic parameters of osthole between osthole administration alone and co‑administration with borneol. When combined with synthetic borneol, the AUC0‑t, AUC0‑∞ and Cmax of osthole increased by 48.153, 104.708 and 92.630%, respectively, while the CL/F decreased by 51.251%. When combined with (+)‑borneol, the AUC0‑t, AUC0‑∞ and Cmax of osthole were increased by 61.561, 78.167, and 51.769%, respectively, while the CL/F decreased by 44.174% (P<0.01). In addition, when combined with (‑)‑borneol, the AUC0‑t, AUC0‑∞ and Cmax of osthole increased by 115.856, 167.786 and 271.289%, respectively, while the CL/F decreased by 60.686% (P<0.01). These results indicated that borneol may enhance gastrointestinal absorption and inhibit the metabolism of osthole. In addition, the promotional effect of (‑)‑borneol on the pharmacokinetic parameters of osthole was greater than that of (+)‑borneol.


  • Enhanced anti-tumor activity and reduced toxicity by combination andrographolide and bleomycin in ascitic tumor-bearing mice

    by Huizhen Guo, Zhenbiao Zhang, Zuqing Su, Chaoyue Sun, Xie Zhang, Xiaoning Zhao, Xiaoping Lai, Ziren Su, Yucui Li, Janis Yaxian Zhan